Loading
PC
Progressive Care Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Barreto Rodney, was filed 30 Jun 2023.
Progressive Care Inc.: what insiders have been doing
Every trade that managers of Progressive Care Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector. Progressive Care Inc. has had no insider filing for more than a year; the last one goes back to 23 October 2023.
Looking back to 2021, when coverage begins, insiders filed 10 purchases and 8 sales.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
43
Thresholds
n/a
Buy Volume
€2M
10 ops. · all time
Sell Volume
€5M
8 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$35M
Gross profitUS$8.4M24% margin
Net income-US$5.1M-14.5% margin
Last declaration on 23 October 2023
Declarations43 total
15,000 shares@ US$3.1647.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-028721:0
11,111 shares@ US$4.5052.3% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-028723:0
112,838 shares@ US$4.455.9% of flowCommon StockSEC:0001437749-23-028657:1
190,000 shares@ US$2.204.9% of flowCommon StockSEC:0001437749-23-028657:2
93,932 shares@ US$4.454.9% of flowCommon StockSEC:0001437749-23-028657:3
455,000 shares@ US$2.2011.7% of flowCommon StockSEC:0001437749-23-028657:4
224,944 shares@ US$4.4511.7% of flowCommon StockSEC:0001437749-23-028657:5
340,599 shares@ US$2.208.7% of flowCommon StockSEC:0001437749-23-028657:6
168,386 shares@ US$4.458.7% of flowCommon StockSEC:0001437749-23-028657:7
230,000 shares@ US$2.205.9% of flowCommon StockSEC:0001437749-23-028657:8
112,838 shares@ US$4.456.8% of flowCommon StockSEC:0001437749-23-028658:1
30,000 shares@ US$2.200.9% of flowCommon StockSEC:0001437749-23-028658:2
14,831 shares@ US$2.200.4% of flowCommon StockSEC:0001437749-23-028658:3
455,000 shares@ US$2.2013.6% of flowCommon StockSEC:0001437749-23-028658:4
224,944 shares@ US$4.4513.6% of flowCommon StockSEC:0001437749-23-028658:5
340,599 shares@ US$2.2010.2% of flowCommon StockSEC:0001437749-23-028658:6
168,386 shares@ US$4.4510.2% of flowCommon StockSEC:0001437749-23-028658:7
230,000 shares@ US$2.206.9% of flowCommon StockSEC:0001437749-23-028658:8
228,240 shares@ US$2.2050.2% of flowCommon StockSEC:0001437749-23-028657:0
228,240 shares@ US$2.2050.2% of flowCommon StockSEC:0001437749-23-028658:0
8,197 shares@ US$6.1052.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023803:0
15,000 shares@ US$3.1647.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023805:0
8,929 shares@ US$5.6033.5% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023801:0
9,311 shares@ US$5.37100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023359:0
15,000 shares@ US$3.1631.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023357:0
25 of 43 declarations
About Progressive Care Inc.
Progressive Care Inc. is a United States healthcare company that built its business around pharmacy services, patient support, and healthcare data/administration solutions. Founded in 2005 and incorporated in Delaware on October 31, 2006, the company developed as a niche operator focused on retail pharmacy, contract pharmacy services, and clinical support offerings. Its operational base has been in Hallandale Beach, Florida, United States. Over time, Progressive Care combined pharmacy dispensing with managed-care support functions, allowing it to address a fragmented but highly regulated corner of the healthcare market.
The company’s main business lines include retail pharmacy operations, prescription fulfillment, compounded medications, 340B contract pharmacy services, medication therapy management (MTM), third-party administration and billing support, telepharmacy services, and supply arrangements for long-term care facilities. It has also offered COVID-19 diagnostics and vaccination services, along with data management and practice risk-management solutions for healthcare organizations. This mix gives the business exposure both to pharmacy economics and to administrative services that help clients manage reimbursement, compliance, and patient engagement.
Read moreShow less
From a competitive standpoint, Progressive Care operates in a crowded landscape that includes large national pharmacy chains, integrated pharmacy benefit and healthcare service platforms, and specialized long-term-care pharmacy operators. Its relative positioning has been based less on scale and more on specialization, local execution, and access to niche reimbursement frameworks such as 340B. For investors, that means the equity has historically carried the characteristics of a small-cap/micro-cap healthcare name: operational leverage can be meaningful, but so can customer concentration, reimbursement pressure, and execution risk.
In market terms, Progressive Care was formerly quoted on OTCQB under the symbol RXMD. A major corporate event occurred on October 1, 2024, when Progressive Care completed its merger with NextPlat Corp and became a wholly owned subsidiary of NextPlat, which is listed on NASDAQ in the United States. As a result, investors should now view Progressive Care’s healthcare operations within the broader NextPlat reporting structure rather than as a standalone public issuer. Recent developments included improved 2024 operating momentum, supported by additional 340B pharmacy service agreements and stronger prescription volumes at PharmcoRx locations. The key analytical question going forward is whether those healthcare operations can sustain growth and margin improvement inside the NextPlat platform while preserving the specialization that originally differentiated the business.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
